Blockade of neurotensin receptors during amphetamine discontinuation indicates individual variability

Neuropeptides

Volumn 41, Issue 2, 2007, Pages 83-91

  Costa, Fabiana G ^a   Frussa Filho, Roberto ^b   Canteras, Newton S ^a   Valera, Adriana G ^a   Felicio, Luciano F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Accumbens; Addiction; Limbic activation; Locomotor activity; Mice; Withdrawal

Indexed keywords

2 [[1 (7 CHLORO 4 QUINOLINYL) 5 (2,6 DIMETHOXYPHENYL) 3 PYRAZOLYL]CARBONYLAMINO] 2 ADAMANTANECARBOXYLIC ACID; AMPHETAMINE; NEUROTENSIN RECEPTOR; NEUROTENSIN RECEPTOR ANTAGONIST; PROTEIN FOS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; LOCOMOTION; MALE; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIZATION;

AMPHETAMINE; AMPHETAMINE-RELATED DISORDERS; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; EXPLORATORY BEHAVIOR; IMMUNOHISTOCHEMISTRY; LIMBIC SYSTEM; MALE; MICE; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; PROTO-ONCOGENE PROTEINS C-FOS; PYRAZOLES; QUINOLINES; RECEPTORS, NEUROTENSIN; SUBSTANCE WITHDRAWAL SYNDROME;

ANIMALIA; MUS;

EID: 33847399119     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2006.12.001     Document Type: Article

References (47)

1. Azzi M., Betancur C., Sillaber I., Spanagel R., Rostene W., and Berod A. Repeated administration of the neurotensin receptor antagonist SR48692 differentially regulates mesocortical and mesolimbic dopaminergic systems. J. Neurochem. 71 (1998) 1158-1167
2. Betancur C., Cabrera R., Kloet E.R., Pélaprat D., and Rostène W. Role of endogenous neurotensin in the behavioral and neuroendrocrine effects of cocaine. Neuropsychopharmacology 19 (1998) 322-332
3. Boudin H., Pélaprat D., Rostène W., and Beaudet A. Cellular distribution of neurotensin receptors in rat brain: immunohistochemical study using an antipeptide antibody against the cloned high affinity receptor. J. Comp. Neurol. 373 (1996) 76-89
4. Boulay D., Duterte-Boucher D., Nouel D., and Costentin J. Locomotor sensitization to [D-Trp11]neurotensin after repeated injections of the dopamine uptake inhibitor GBR12783 in rats. Neurosci. Lett. 208 (1996) 5-8
5. Cador M., Bjijou Y., and Stinus L. Evidence for a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine. Neuroscience 65 (1995) 385-395
6. Chefer V.I., Zakharova I., and Shippenberg T.S. Enhanced responsiveness to novelty and cocaine is associated with decreased basal dopamine uptake and release in the nucleus accumbens: quantitative microdialysis in rats under transient conditions. J. Neurosci. 23 (2003) 3076-3084
7. Costa F.G., Frussa-Filho R., and Felicio L.F. The neurotensin receptor antagonist, SR48692, attenuates the expression of amphetamine-induced behavioural sensitisation in mice. Eur. J. Pharmacol. 428 (2001) 97-103
8. Crombag H.S., Jedynak J.P., Redmond K., Robinson T.E., and Hope B.T. Locomotor sensitization to cocaine is associated with increased Fos expression in the accumbens, but not in the caudate. Behav. Brain Res. 136 (2002) 455-462
9. Dobner P.R., Deutch A.Y., and Fadel J. Neurotensin: dual roles in psychostimulant and antipsychotic drug responses. Life Sci. 73 (2003) 801-811
10. During M.J., Bean A.J., and Roth R.H. Effects of CNS stimulants on the in vivo release of the colocalized transmitters, dopamine and neurotensin, from rat prefrontal cortex. Neurosci. Lett. 140 (1992) 129-133
11. Gawin F.H., and Ellinwood E.H. Cocaine and other stimulants: actions, abuse and treatments. N. Engl. J. Med. 318 (1988) 1173-1182
12. Gully D., Canton M., Boigegrain R., Jean F., Molimard J., Poncelet M., Gueudet C., Heaulme M., Leyris R., Brouard A., Pelaprat D., Labbé-Jullié C., Mazella J., Soubrié P., Maffrand J.P., Rostène W., Kitabgi P., and Le Fur G. Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor. Proc. Natl. Acad. Sci. USA 90 (1993) 65-69
13. Hertel P., Mathe J.M., Nomikos G.G., Iurlo M., Mathe A.A., and Svensson T.H. Effects of d-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat. Behav. Brain Res. 72 (1995) 103-114
14. Hooks M.S., Jones G.H., Smith A.D., Neill D.B., and Justice Jr. J.B. Individual differences in locomotor activity and sensitization. Pharmacol. Biochem. Behav. 38 (1991) 467-470
15. Hooks M.S., Jones G.H., Neill D.B., and Justice Jr. J.B. Individual differences in amphetamine sensitization: dose-dependent effects. Pharmacol. Biochem. Behav. 41 (1992) 203-210
16. Horger B.A., Taylor J.R., Elsworth J.D., and Roth R.H. Preexposure to, but not cotreatment with, the neurotensin antagonist SR 48692 delays the development of cocaine sensitization. Neuropsychopharmacology 11 (1994) 215-222
17. Hsu S.M., and Raine L. Protein A, avidin, and biotin in immunohistochemistry. J. Histochem. Cytochem. 29 (1981) 1349-1353
18. Kalivas P.W. Neurocircuitry of addiction. In: Davis K.L., Charney D., Coyle J.T., and Nemeroff C. (Eds). Neuropsychopharmacology: The Fifth Generation of Progress (2002), Lippincott Williams and Wilhins, Philadelphia 1357-1366
19. Kalivas P.W., and Duffy P. Effect of acute and daily neurotensin and enkephalin treatments on extracellular dopamine in the nucleus accumbens. J. Neurosci. 10 (1990) 2940-2949
20. Kalivas P.W., Sorg B.A., and Hooks M.S. The pharmacology and neural circuitry of sensitization to psychostimulants. Behav. Pharmacol. 4 (1993) 315-334
21. Kasckow J., and Nemeroff C.B. Neurobiology of neurotensin: focus on neurotensin-dopamine interactions. Regul. Pept. 36 (1991) 153-164
22. Kinkead B., and Nemeroff C.B. Neurotensin: an endogenous antipsychotic?. Curr. Opin. Pharmacol. 2 (2002) 99-103
23. Li Y., Hu X.T., Berney T.G., Vartanian A.J., Stine C.D., Wolf M.E., and White F.J. Both glutamate receptor antagonists and prefrontal cortex lesions prevent induction of cocaine sensitization and associated neuroadaptations. Synapse 34 (1999) 169-180
24. Marinelli M., and White F.J. Enhanced vulnerability to cocaine self-administration is associated with elevated impulse activity of midbrain dopamine neurons. J. Neurosci. 20 (2000) 8876-8885
25. Nemeroff C.B. The interaction of neurotensin with dopaminergic pathways in the central nervous system: basic neurobiology and implications for the pathogenesis and treatment of schizophrenia. Psychoneuroendocrinology 11 (1986) 15-37
26. Nicot A., Rostène W., and Berod A. Neurotensin receptor expression in the rat forebrain and midbrain: a combined analysis by in situ hybridization and receptor autoradiography. J. Comp. Neurol. 341 (1994) 407-419
27. Panayi F., Dorso E., Lambas-Senas L., Renaud B., Scarna H., and Berod A. Chronic blockade of neurotensin receptors strongly reduces sensitized, but not acute, behavioral response to d-amphetamine. Neuropsychopharmacology 26 (2002) 64-74
28. Parelkar N.K., and Wang J.Q. mGluR5-dependent increases in immediate early gene expression in the rat striatum following acute administration of amphetamine. Brain Res. Mol. Brain Res. 122 (2004) 151-157
29. Piazza P.V., Deminière J., Moal M.L., and Simon H. Factors that predict individual vulnerability to amphetamine self-administration. Science 245 (1989) 1511-1513
30. Pierce R.C., and Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. Rev. 25 (1997) 192-216
31. Pierre P.J., and Vezina P. Predisposition to self-administer amphetamine: the contribution of response to novelty and prior exposure to the drug. Psychopharmacology (Berl) 129 (1997) 277-284
32. Robinson T.E., and Becker J.B. Changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. 396 (1986) 157-198
33. Robinson T.E., and Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18 (1993) 247-291
34. Rompré P.P. Repeated activation of neurotensin receptors sensitizes to the stimulant effect of amphetamine. Eur. J. Pharmacol. 328 (1997) 131-134
35. Rompré P.P., and Perron S. Evidence for a role of endogenous neurotensin in the initiation of amphetamine sensitization. Neuropharmacology 39 (2000) 1880-1892
36. Self D.W., and Nestler E.J. Relapse to drug-seeking: neural and molecular mechanisms. Drug Alcohol Depend. 51 (1998) 49-60
37. Seroogy K.B., Mehta A., and Fallon J.H. Neurotensin and cholecystokinin coexistence within neurons of the ventral mesencephalon projections to forebrain. Exp. Brain Res. 68 (1987) 277-289
38. Sesack S.R., and Pickel V.M. In the rat medial nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons and are in apposition to each other. Brain Res. 527 (1990) 266-279
39. Sesack S.R., and Pickel V.M. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J. Comp. Neurol. 320 (1992) 145-160
40. Shim I., Javaid J.I., Wirtshafter D., Jang S.Y., Shin K.H., Lee H.J., Chung Y.C., and Chun B.G. Nicotine-induced behavioral sensitization is associated with extracellular dopamine release and expression of c-Fos in the striatum and nucleus accumbens of the rat. Behav. Brain Res. 121 (2001) 137-147
41. Steinberg R., Brun P., Fournier M., Souilhac J., Rodier D., Mons G., Terranova J.P., Le Fur G., and Soubrié P. SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behaviour and changes in dopaminergic transmission. Neuroscience 59 (1994) 921-929
42. Todtenkopf M.S., Mihalakopoulos A., and Stellar J.R. Withdrawal duration differentially affects c-Fos expression in the medial prefrontal cortex and discrete subregions of the nucleus accumbens in cocaine-sensitized rats. Neuroscience 114 (2002) 1061-1069
43. Uhl G.R., Kuhar M.J., and Snyder S.H. Neurotensin: immunohistochemical localization in rat central nervous system. Proc. Natl. Acad. Sci. USA 74 (1977) 4059-4063
44. Vanderschuren L.J., Schmidt E.D., De Vries T.J., Van Moorsel C.A., Tilders F.J., and Schoffelmeer A.N. A single exposure to amphetamine is sufficient to induce long-term behavioral, neuroendocrine, and neurochemical sensitization in rats. J. Neurosci. 19 (1999) 9579-9586
45. Vezina P. Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: an in vivo microdialysis study in the rat. Brain Res. 605 (1993) 332-337
46. White F.J., and Kalivas P.W. Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend. 51 (1998) 141-153
47. Wolf M.E., Dahlin S.L., Hu X.T., Xue C.J., and White K. Effects of lesions of prefrontal cortex, amygdale, or fornix on behavioral sensitization to amphetamine. Comparison with N-methyl-d-aspartate antagonists. Neuroscience 69 (1995) 417-439